Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Few Seek Cure for Rare Disease Amyloidosis Jeanne Caliguiri: 'No Progress to Report, I'm Sorry to Say'

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Few Seek Cure for Rare Disease Amyloidosis Jeanne Caliguiri: 'No Progress to Report, I'm Sorry to Say'

Article excerpt

The race to untangle the mystery of amyloidosis, a rare blood disorder, has recruited both running fans and researchers in Pittsburgh. Despite the rally of support that followed the 1988 death of Richard S. Caliguiri from the disease, though, the research fund created in his name has had little impact on the effort to find a cure.

Mr. Caliguiri, the longtime Pittsburgh mayor for whom Sunday's Great Race is named, was 56 when he died. The race is now in its 35th year and since 2003 has been the principal source of funding for the Richard S. Caliguiri Amyloidosis Research Fund, created by his widow, Jeanne.

A dollar from each entry fee goes to the fund managed by the Pittsburgh Foundation, now with a balance of more than $1.6 million. The total contributed from the race since 2007 is $63,276.

But because the disease is rare -- only between 1,200 and 3,000 cases are diagnosed in the U.S. each year -- there are few researchers. And because the fund is restricted to local research, it hasn't been available to major research organizations elsewhere.

"There's no progress to report [in finding a cure], I'm sorry to say," said Ms. Caliguiri, who is retiring this year as director of development for the Leukemia & Lymphoma Society. "Maybe that's partly my fault. When I set up this fund, I insisted that the money be spent here locally." She said she didn't plan to change the terms of the fund.

Amyloidosis is the buildup of an abnormal protein that forms deposits in the body's organs and tissues and can interfere with organ functions. The disorder is most likely to be life-threatening if the amyloids accumulate in the heart or the kidneys. It can occur by itself, or as the result of another illness. There is also an inherited form of the disease.

Primary amyloidosis is related to excess production of antibodies by plasma cells, but its cause is unknown.

Because there are so few amyloidosis researchers, they are in high demand. Suzanne Lentzsch was the only Western Pennsylvania doctor the Amyloidosis Foundation recommended on its website. But in May, Dr. Lentzsch left UPMC for Columbia University.

"This happens all the time here," said Roy Smith, hematologist and medical oncologist at UPMC's Hillman Cancer Center. "We get some really great people here. But as they become more accomplished, every large institution wants them on their team."

Some Caliguiri-funded UPMC research has focused on early diagnosis and new tests for detecting the disease.

"Amyloidosis is sufficiently uncommon that primary care physicians may not recognize when and how to test for this disease," the Amyloidosis Foundation says.

Symptoms include fatigue, shortness of breath, weight loss, lack of appetite, numbness, tingling, weakness, enlarged tongue and swelling. A tissue biopsy is the only way to tell if a patient is suffering from amyloidosis and not from some more common and less serious ailment with the same symptoms. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.